Related Experiment Video
Updated: Jul 13, 2026

10:16
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery
Gerben A Koning1, Gerard C Krijger
1Laboratory Experimental Surgical Oncology, Department of Surgical Oncology, Erasmus MC, Rotterdam, The Netherlands. g.koning@erasmusmc.nl
Anti-Cancer Agents in Medicinal Chemistry
|July 17, 2007
Summary
Lipid-based nanocarriers enhance cancer treatment by improving drug delivery and reducing toxicity. Future applications involve combining therapeutic and imaging agents for image-guided drug delivery and monitoring.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Lipid-based nanocarriers are clinically used for chemotherapy delivery.
- These systems improve drug efficacy by altering pharmacokinetics and biodistribution.
- Enhanced tumor accumulation is achieved due to leaky tumor vasculature.
Purpose of the Study:
- To review the current status and challenges in nanocarrier-aided drug delivery and targeting.
- To discuss combining imaging probes with drug carriers for multifunctional nanocarriers.
- To explore the potential of these nanocarriers in image-guided drug delivery.
Main Methods:
- Review of current literature on lipid-based nanocarriers for drug delivery and targeting.
- Discussion of advancements in cell-specific targeting and controlled release.
- Exploration of integrating imaging agents with therapeutic nanocarriers.
Main Results:
- Lipid-based nanocarriers demonstrate increased therapeutic efficacy and reduced toxicity in cancer treatment.
- Targeted nanocarriers show potential in animal models, awaiting clinical application.
- Multifunctional nanocarriers merging therapeutic and imaging agents are emerging.
Conclusions:
- Multifunctional nanocarriers offer significant potential for image-guided drug delivery.
- Online monitoring of tumor targeting and drug release will be enabled.
- Further development is crucial for clinical translation of advanced nanocarrier systems.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

